Where are Temozolomide capsules produced?

Taidao is the brand name of Temozolomide marketed in China. Temozolomide capsules are an alkylating agent anti-cancer chemotherapy drug used to treat severe brain cancer. It is most commonly used as a second-line treatment for astrocytoma and a first-line treatment for glioblastoma. It is produced by a number of pharmaceutical companies and approved by the U.S. Food and Drug Administration. The pharmaceutical companies approved for marketing by the Food and Drug Administration (FDA) are produced by Merck, but pharmaceutical companies producing temozolomide capsules include but are not limited to pharmaceutical companies from the United States, Europe, India and China. , common specifications are 5mg, 20mg, 100mg, 140mg, 180mg and 250mg.